Abstract
Case histories of outpatients with community-acquired pneumonia (CAP) who had not required hospitalization were randomly selected in seven regions of Russia for retrospective analysis. Diagnoses were classified according to the ICD-10; antimicrobials – to the ATC classification. Altogether 778 case histories of patients aged from 16 to 88 (average age 47,1±17,2) were included in the study. The most frequently prescribed group of medications were antimicrobials for systemic use (99,5%), anti-cough and anti-inflammatory preparations (75,5%), vitamins (24,0%) and antihistamines (23,4%). In 71,4% of cases antimicrobials were administered orally, in 28,6% – parenterally. The most common antimicrobial prescribed was gentamycin (29,3%), followed by co-trimoxazole (22,7%), ampicillin (20,3%) and ciprofloxacin (17,2%). For initial antimicrobial treatment monotherapy was used in 83,6% of cases (gentamycin in 18,7%, ampicillin – 14,5%, ciprofloxacin – 12,5). Combination of 2–3 antibiotics as initial therapy received 16,4% of patients; the most frequently prescribed combinations were ampicillin + co-trimoxazole (24,4%) and gentamycin + co-trimoxazole (8,7%). Average duration of antimicrobial therapy was 9,9±4,7 days. Unacceptably large number of various antibiotics was used for treatment of CAP. Most of the «popular» antibiotics are not recommended for empirical therapy by the current guidelines. Further studies are advisable to clarify the reasons for such prescription habits.
-
1.
Чучалин А.Г. Болезни органов дыхания. Мед газ 2000; 43:8-9.
-
2.
Bartlett J.G., Breiman R.F., Mandell L.A., Thomas M.F. Jr. Community-acquired pneumonia in adults: Guidelines for management. Clin Inf Dis 1998; 26: 811-38.
-
3.
Baldwin D.R., Macfarlane J.T. Community-acquired pneumonia. In: Armstrong D., Cohen J., editors. Infectious Diseases. London: Harcourt Publishers Ltd; 1999. p. 27.1-27.10.
-
4.
Donowitz G.R., Mandell G.L. Acute pneumonia. In: Mandell G.L., Bennett J.E., Dolin R. editors. Principles and Practice of Infectious Diseases. 5th ed. Philadelphia: Churchill Livingstone; 2000. p. 717-43.
-
5.
Навашин С.М., Чучалин А.Г., Белоусов Ю.Б. и др. Антибактериальная терапия пневмоний у взрослых. Учебно-методическое пособие для врачей. М; 1998.
-
6.
Стандарты (протоколы) диагностики и лечения больных неспецифическими заболеваниями легких (взрослое население). Прил. к приказу № 300 Минздрава РФ "Об утверждении стандартов (протоколов) диагностики и лечения больных с неспецифическими заболеваниями легких" от 09.10.98 г.
-
7.
Woodhead M. Community-acquired pneumonia guidelines – an international comparison. A view from Europe. Chest 1998; 113:183-7.
-
8.
Quintiliani R., Quintiliani R. Jr., Nightingale C.N. Aminoglycosides. In: Armstrong D., Cohen J., editors. Infectious Diseases. London: Harcourt Publishers Ltd; 1999. Vol. 2. p. 7.11-7.12.
-
9.
Gilbert D.N. Aminoglycosides. In: Mandell G.L., Bennett J.E., Dolin R. editors. Principles and Practice of Infectious Diseases. 5th ed. Philadelphia: Churchill Livingstone; 2000. p. 307-36.
-
10.
Hooper D.C. Quinolones. In: Mandell G.L., Bennett J.E., Dolin R., editors. Principles and Practice of Infectious Diseases. 5th ed. Philadelphia: Churchill Livingstone; 2000. p. 404-23.
-
11.
Chen D.K., McGeer A., de Azavedo J.C., Low D.E, for the Canadian Bacterial Surveillance Network. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. N Engl J Med 1999; 341: 233-9.
-
12.
Страчунский Л.С., Богданович Т.М. Состояние антибиотикорезистентности в России. Антибактериальная терапия. Практическое руководство. Под ред. Страчунского Л.С., Белоусова Ю.Б., Козлова С.Н. М.; 2000. с. 7-11.
-
13.
Страчунский Л.С. Козлов Р.С. Современные взгляды на применение ко-тримоксазола. Клин фармакол тер 1997; 6: 27-31.
-
14.
Huchon G., Woodhead M., Gialdroni-Grassi G., et al. Guidelines for management of adult community-acquired lower respiratory tract infections. Eur Resp J. 1998; 11: 986-91.
-
15.
Mandell G.L., Perti W.A., Jr. Penicillins, Cephalosporins, and other b-lactam antibiotics. In: Hardman J.G., Limbird L.E., Molinoff P.B., Ruddon R.W., editors. Goodman and Gilman's. The Pharmacological Basis of Therapeutics. 9th ed. New York: McGraw-Hill; 1996. p. 1073-102.
-
16.
Страчунский Л.С., Козлов С.Н. Макролиды в современной клинической практике. Смоленск; 1998.
-
17.
Carbon C., Ariza H., Rabie W.J., et al. Comparative study of levofloxacin and amoxycillin/clavulanic acid in adults with mild-to-moderate community-acquired pneumonia. Clin Microbiol Infect 1999; 5: 724-32.
-
18.
Ortqvist A., Valtonen M., Cars O., et al. Oral empiric treatment of community-acquired pneumonia – a multicenter, double-blind, randomized study comparing sparfloxacin with roxithromycin. Chest 1996; 110: 1499-506.